# RealizedCare

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/realizedcare

- Industry: Healthcare IT
- Headquarters: Elizabethtown, US
- Website: www.realizedcare.com/
- Total disclosed funding: $14M
- Latest round: Series B (Dec 13, 2022)
- Investors on record: 9

## About

BehaVR, Inc. is a US-based company that focuses on delivering innovative AI-driven extended reality solutions designed for therapeutic applications in healthcare, enhancing treatment for both physical and mental health conditions.Founded in 2016 in Elizabethtown, US, BehaVR, Inc. specializes in developing technology-based therapeutic solutions. The company has undergone strategic developments to enhance its offerings. The founder and CEO, Aaron Gani, has a history of leadership in relevant fields. Recently, on February 18, 2025, BehaVR secured USD 13.000 mn in a Series B funding round, attracting investments from firms like Accenture Technology Ventures and Optum Ventures. The total amount raised by the company stands at USD 13.000 mn.BehaVR, Inc. offers AI-driven extended reality (XR) solutions for therapeutic applications in healthcare. Its products include immersive environments designed for pain management, cognitive therapy, and rehabilitation, addressing both physical and mental health issues. Clinicians utilize their advanced AI platform to create personalized treatment plans, making it vital for healthcare organizations, therapists, and patients facing chronic pain, anxiety, and cognitive disorders. The company's services cater to diverse regions, including the USA, Australia, Israel, Spain, and broader Europe.BehaVR operates on a B2B revenue model, providing subscription-based services to healthcare providers and institutions. Clients access the XR therapeutic platform via various pricing plans, facilitating scalability. Key products like the XR Clinician AI Assistant integrate into existing clinical workflows, promoting patient care continuity while enhancing operational efficiency. The company’s collaborations with healthcare organizations further augment revenue through initiatives aimed at improving patient outcomes.Looking ahead, BehaVR plans to expand its product line by integrating RealizedCare’s digital therapeutics and triage tools, enhancing patient care for chronic pain and mental health management. The company is targeting expansion into new markets, particularly focusing on additional regions in Europe and Australia before the end of 2025. The recent funding from its Series B round will support these initiatives, enabling BehaVR to enhance its AI-powered therapeutic platform and meet growing demand in these territories.

## Funding rounds

- Series B, Dec 13, 2022, $13M — Chrysalis Ventures, Accenture Technology Ventures, Oxford Sciences Enterprises, Optum Ventures, Confluent Health, LLC, Thornton Capital Management
- Seed, Nov 5, 2018 — City Light Capital
- Seed, Apr 1, 2018, $1M — Kentucky Science and Technology Corporation, Arkitekt Ventures

## Investors

- Kentucky Science and Technology Corporation — Seed
- Arkitekt Ventures (https://capitalatlas.ai/funds/arkitekt-ventures) — Seed
- City Light Capital (https://capitalatlas.ai/funds/city-light-capital) — Seed
- Chrysalis Ventures (https://capitalatlas.ai/funds/chrysalis-ventures) — Series B
- Accenture Technology Ventures (https://capitalatlas.ai/funds/accenture-technology-ventures) — Series B
- Oxford Sciences Enterprises (https://capitalatlas.ai/funds/oxford-sciences-enterprises) — Series B
- Optum Ventures (https://capitalatlas.ai/funds/optum-ventures) — Series B
- Confluent Health, LLC — Series B
- Thornton Capital Management — Series B
